Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells - Wikidata - wikimedia - TriplyDB

Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells

Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells

http://www.wikidata.org/entity/Q34236324

about

Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables Plasmodium Infection Is Associated with Impaired Hepatic Dimethylarginine Dimethylaminohydrolase Activity and Disruption of Nitric Oxide Synthase Inhibitor/Substrate Homeostasis Effects of the antioxidant drug tempol on renal oxygenation in mice with reduced renal mass.Impaired endothelial function and microvascular asymmetrical dimethylarginine in angiotensin II-infused rats: effects of tempol.Serelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin II-induced hypertension.Activation of nuclear factor erythroid 2-related factor 2 coordinates dimethylarginine dimethylaminohydrolase/PPAR-γ/endothelial nitric oxide synthase pathways that enhance nitric oxide generation in human glomerular endothelial cells.NOX1, 2, 4, 5: counting out oxidative stress.Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis--a randomized cross-over study.Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension.PRMT1 and PRMT4 Regulate Oxidative Stress-Induced Retinal Pigment Epithelial Cell Damage in SIRT1-Dependent and SIRT1-Independent Manners.Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury.Total flavonoids from Plumula Nelumbinis suppress angiotensin II-induced fractalkine production by inhibiting the ROS/NF-κB pathway in human umbilical vein endothelial cells.Oxidative stress and endothelial dysfunction: therapeutic implications.Antioxidant Therapy: Is it your Gateway to Improved Cardiovascular Health?Renin-Angiotensin system inhibitors reduce serum asymmetric dimethylarginine levels and oxidative stress in normotensive patients with chronic kidney disease.Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.Thromboxane prostanoid receptors enhance contractions, endothelin-1, and oxidative stress in microvessels from mice with chronic kidney disease.Arginine methylation dysfunction increased risk of acute coronary syndrome in coronary artery disease population: A case-control study.Oxidative stress improves coronary endothelial function through activation of the pro-survival kinase AMPK.The role of adipose tissue asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in adipose tissue phenotype and metabolic abnormalities in subtotally nephrectomized rats.Augmented endothelial-specific L-arginine transport prevents obesity-induced hypertension.Salt-sensitive hypertension in mitochondrial superoxide dismutase deficiency is associated with intra-renal oxidative stress and inflammation.Mitochondrial redox plays a critical role in the paradoxical effects of NAPDH oxidase-derived ROS on coronary endothelium.Post-Transcriptional Regulation of Hepatic DDAH1 with TNF Blockade Leads to Improved eNOS Function and Reduced Portal Pressure In Cirrhotic Rats.Relation of Serum ADMA, Apelin-13 and LOX-1 Levels with Inflammatory and Echocardiographic Parameters in Hemodialysis Patients.Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial.Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency.High-salt diet induces outward remodelling of efferent arterioles in mice with reduced renal mass.Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-to-inhibitor ratio: the Hoorn Study.Regulation of fluid reabsorption in rat or mouse proximal renal tubules by asymmetric dimethylarginine (ADMA) & dimethylarginine dimethylaminohydrolase (DDAH) 1.Impaired Endothelial Function in Hereditary Angioedema During the Symptom-Free Period.Apocynin attenuates oxidative stress and hypertension in young spontaneously hypertensive rats independent of ADMA/NO pathway

P2860

Q26865426-4C581A7D-8117-4950-90E0-D19582331ACF Q27317763-C1FA2BA2-C7E1-4B91-8D72-D18B8A4FA933 Q30418412-B500FBE8-2253-433B-BAB7-6E3B31F61DCC Q34721777-6D3E5769-7BA6-4C4E-8FDD-BC7C31D59566 Q34726868-EDB61FE2-6A49-4D47-A241-48AB14DB77F6 Q35175624-4860A9B7-67C7-437B-B4FB-E52A31868193 Q35375986-06AD04A1-E5C4-4B24-AEA6-9CF2282EC71C Q35757606-E82344B7-6688-475C-A508-3A12317FC490 Q35818228-BE0FBB94-B66A-40A3-90AA-1064AE6C1A71 Q35933350-B2172377-909C-4746-9AA0-86DD7FEDE980 Q36259933-35663F80-D6FF-43FC-A5C7-D77441111381 Q37621347-078F3DAF-2DFF-4DC9-A141-F034817CB7E5 Q37709969-3BD1D756-5F42-4AAD-953A-9068E4B4A9A7 Q37834017-ACA3675E-29AE-44C9-9EDF-56A4DA8E0DC9 Q38501183-B1B0EF3C-2CA8-46DF-B59D-53116DD6D9B7 Q38629539-D4A990F6-24DE-410B-905A-84D8267AAE53 Q39116577-0F386F78-3AF3-40AA-87EA-1A4D93DE3DB8 Q41667552-26A417D0-ADF8-4691-BF3F-A0415F6DA5F6 Q42040317-7095765F-F82A-4E59-AAC0-C37CDE13A7E5 Q42589408-95C48B78-5D4F-4488-ABCD-F498062CD7BA Q42818947-ABB6C189-09FF-45B2-A0A8-3E2CF158A8B8 Q44178718-6687C355-D173-434B-8EED-3EADE16692A4 Q44752587-803EC656-2F18-4D59-B05C-EB3FDACE2A1E Q46432453-A960E428-1350-4167-9365-974F99563EDD Q47134026-28D7F0E6-F4EC-4F12-9967-A8AC3DDFE5DC Q47330030-2C4B1B5A-5B9C-4E63-B0C9-A51C75B1D05D Q48315547-A1FFA713-D5AE-4687-B506-E71C15F5FC44 Q49154688-4EF8A138-CA18-4819-8FBD-36203CE0D2C4 Q50321069-100C28C2-E6C6-4DAA-A62F-257A597F7349 Q51506465-5A78EBE6-7558-4217-BF96-D6C8969A30CD Q52669796-4FBD6012-B22C-4860-9DDE-756768A5E58E Q55230947-5D929963-3352-439A-B34B-BE9E93C82ED5 Q57845657-34735F7C-559F-4C6C-9AB0-F0B349CBD919

P2860

Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells

http://www.wikidata.org/entity/Q34236324

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells

@ast

Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells

@en

Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells

@nl

type

label

Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells

@ast

Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells

@en

Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells

@nl

prefLabel

Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells

@ast

Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells

@en

Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells

@nl

P1433

Q34236324-464747CE-CC5F-4155-A033-B97E6A9EA80C

P1476

Q34236324-8A8C0C27-22A3-4CFE-8CCD-DD77E0AF2330

P2093

Q34236324-7B09A54B-2D92-4C88-9588-BAB56154BF29

Q34236324-CE1182BB-EEFE-4E64-8E06-587CC66852E0

Q34236324-E1A5A540-EB1B-4415-BBD7-8BFC71CB817A

Q34236324-E7D26E06-C745-4E72-8D18-DC6ED1DE6773

Q34236324-F7B2E10C-C7D4-483F-AE77-89DFAAB420F0

P2860

Q34236324-2DB2B097-B96B-4692-AE50-1D64E5165128

Q34236324-32F7FB72-3086-4EEF-A950-A036D5601213

Q34236324-3A9DB8F1-947B-4C88-991D-487CAAFE649F

Q34236324-4726481B-88D8-4DA0-8ED8-3E442679F4CB

Q34236324-4929448C-D1A2-41D9-BFEF-2B6515FB868A

Q34236324-53D6C023-352E-4895-B5EF-C698D06FE5B3

Q34236324-552D8C4A-9DFC-4F98-A4F5-F5AE17E2BC21

Q34236324-59E1F9DD-E8F3-4B37-B830-223F8C59A17C

Q34236324-662FEC0C-0C70-461A-A3BC-02725EC3469E

Q34236324-7392BB4A-7643-4B92-8808-C954C0A6F14C

P304

Q34236324-FC588C17-5638-497D-A367-40A9513456C3

P31

Q34236324-D36659B0-2561-457E-AA22-A8C888843ABB

P356

Q34236324-8E1BF29E-89FF-4BBF-BFC1-5DED3C005C0F

P407

Q34236324-9CC29204-74D9-46B0-A3E5-E7C9D1762EFD

P433

Q34236324-9EB1B42C-838A-42B1-8DA8-296CF156C4CD

P478

Q34236324-4B27742B-41EC-4FD2-A41E-3027ACBC9F7D

P50

Q34236324-58154705-11C6-4623-BE03-BA1638069498

P577

Q34236324-C70FD15F-BA1F-4DF3-BBBF-F23536A42558

P5875

Q34236324-F7E029E0-8847-4AAF-80FA-5FF61F8DE146

P698

Q34236324-A90C9F7A-58EE-4114-BB1A-67D7D55E2287

P932

Q34236324-D79836BE-1D3F-4577-ABF5-48C4E8EA7FD5

P356

HYPERTENSIONAHA.110.152959

P1433

P1476

Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells

@en

P2093

Christopher S Wilcox

http://www.w3.org/2001/XMLSchema#string

Shakil Aslam

http://www.w3.org/2001/XMLSchema#string

Tom Teerlink

http://www.w3.org/2001/XMLSchema#string

William J Welch

http://www.w3.org/2001/XMLSchema#string

Zaiming Luo

http://www.w3.org/2001/XMLSchema#string

P2860

S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase

RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response

p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells

Asymmetric dimethylarginine in angiotensin II-induced hypertension

Recent advances in arginine metabolism: roles and regulation of the arginases.

Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.

Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.

Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.

Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension

Comparison of inhibitors of superoxide generation in vascular smooth muscle cells.

P304

498-504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HYPERTENSIONAHA.110.152959

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Kathy K. Griendling

P577

2010-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45583427

http://www.w3.org/2001/XMLSchema#string

P698

20696982

http://www.w3.org/2001/XMLSchema#string

P932

2963313

http://www.w3.org/2001/XMLSchema#string